CNS Pharmaceuticals Inc

CNSP

Company Profile

  • Business description

    CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

  • Contact

    2100 West Loop South
    Suite 900
    HoustonTX77027
    USA

    T: +1 800 946-9185

    https://www.cnspharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    3

Stocks News & Analysis

stocks

What next for the largest company on the ASX?

After a historic rally in 2024, what lies ahead for this overvalued banking titan?
stocks

Ask the analyst: Are IDP Education's woes temporary?

The global education services provider has gone from stock market darling to one of the ASX's weakest performers. What gives?
stocks

Is it time to buy the Magnificent Seven?

After the recent selloff, the bull market’s most in-demand stocks look much cheaper.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,013.3046.700.59%
CAC 408,028.2890.071.13%
DAX 4022,567.14109.27-0.48%
Dow JONES (US)41,488.19674.621.65%
FTSE 1008,632.3389.771.05%
HKSE23,959.98497.332.12%
NASDAQ17,303.01345.44-1.96%
Nikkei 22537,053.10263.070.72%
NZX 50 Index12,266.2557.200.47%
S&P 5005,638.94117.422.13%
S&P/ASX 2007,789.7040.600.52%
SSE Composite Index3,412.3253.591.60%

Market Movers